Literature DB >> 26810225

Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis.

Wei Jiang1, Stéphanie St-Pierre2, Patrick Roy2, Barbara J Morley3, Junwei Hao4, Alain R Simard5.   

Abstract

Myeloid cells, including proinflammatory monocytes and neutrophils, have important roles in the pathology of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). These cells infiltrate the CNS in the early stages of disease development and contribute to the inflammatory response that is associated with symptom severity. It is thus crucial to identify and understand new mechanisms that can regulate the CNS infiltration of proinflammatory myeloid cells. Nicotinic acetylcholine receptors (nAChRs) have been increasingly studied for their immune-regulatory properties. In this study, we assessed the ability of nicotine, an nAChR ligand, to modulate proinflammatory myeloid cell numbers within the bone marrow, spleen, blood, and CNS of EAE mice. We found that nicotine significantly inhibits the infiltration of proinflammatory monocytes and neutrophils into the CNS at time points where these cells are known to play critical roles in disease pathology. In contrast, nicotine does not affect the expansion of other monocytes. We also show that nicotine exerts these effects by acting on α7 and α9 nAChR subtypes. Finally, mRNA transcript levels for CCL2 and CXCL2, chemokines involved in the chemotaxis of proinflammatory monocytes and neutrophils, respectively, are reduced in the brain of nicotine-treated EAE mice before the massive infiltration of these cells. Taken together, our data provide evidence that nAChRs can regulate proinflammatory cell infiltration into the CNS, which could be of significant value for the treatment of neuroinflammatory disorders.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26810225      PMCID: PMC4760232          DOI: 10.4049/jimmunol.1501613

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine.

Authors:  K Matsunaga; T W Klein; H Friedman; Y Yamamoto
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

Review 2.  Heterogeneity of CNS myeloid cells and their roles in neurodegeneration.

Authors:  Marco Prinz; Josef Priller; Sangram S Sisodia; Richard M Ransohoff
Journal:  Nat Neurosci       Date:  2011-09-27       Impact factor: 24.884

3.  Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod.

Authors:  Manoj K Mishra; Janet Wang; Claudia Silva; Mathias Mack; V Wee Yong
Journal:  Am J Pathol       Date:  2012-06-26       Impact factor: 4.307

4.  Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration.

Authors:  Joanna Mikita; Nadège Dubourdieu-Cassagno; Mathilde Sa Deloire; Antoine Vekris; Marc Biran; Gérard Raffard; Bruno Brochet; Marie-Hélène Canron; Jean-Michel Franconi; Claudine Boiziau; Klaus G Petry
Journal:  Mult Scler       Date:  2010-09-02       Impact factor: 6.312

Review 5.  Role of the innate immune system in the pathogenesis of multiple sclerosis.

Authors:  Roopali Gandhi; Alice Laroni; Howard L Weiner
Journal:  J Neuroimmunol       Date:  2010-04-15       Impact factor: 3.478

6.  EMMPRIN: a novel regulator of leukocyte transmigration into the CNS in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Smriti M Agrawal; Claudia Silva; Wallace W Tourtellotte; V Wee Yong
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

7.  Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases.

Authors:  Benoit Aubé; Sébastien A Lévesque; Alexandre Paré; Émilie Chamma; Hania Kébir; Roser Gorina; Marc-André Lécuyer; Jorge I Alvarez; Yves De Koninck; Britta Engelhardt; Alexandre Prat; Daniel Côté; Steve Lacroix
Journal:  J Immunol       Date:  2014-07-21       Impact factor: 5.422

8.  Attenuation of CNS inflammatory responses by nicotine involves α7 and non-α7 nicotinic receptors.

Authors:  Junwei Hao; Alain R Simard; Gregory H Turner; Jie Wu; Paul Whiteaker; Ronald J Lukas; Fu-Dong Shi
Journal:  Exp Neurol       Date:  2010-10-13       Impact factor: 5.330

9.  Neutrophils amplify autoimmune central nervous system infiltrates by maturing local APCs.

Authors:  Karin Steinbach; Melanie Piedavent; Simone Bauer; Johannes T Neumann; Manuel A Friese
Journal:  J Immunol       Date:  2013-09-23       Impact factor: 5.422

10.  Differential modulation of EAE by α9*- and β2*-nicotinic acetylcholine receptors.

Authors:  Alain R Simard; Yan Gan; Stéphanie St-Pierre; Ariana Kousari; Varun Patel; Paul Whiteaker; Barbara J Morley; Ronald J Lukas; Fu-Dong Shi
Journal:  Immunol Cell Biol       Date:  2013-02-12       Impact factor: 5.126

View more
  32 in total

1.  Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production.

Authors:  Zhaoqi Yan; Wei Yang; Luke Parkitny; Sara A Gibson; Kevin S Lee; Forrest Collins; Jessy S Deshane; Wayne Cheng; Amy S Weinmann; Hairong Wei; Hongwei Qin; Etty N Benveniste
Journal:  JCI Insight       Date:  2019-04-02

Review 2.  Neuroimmune interaction in seizures and epilepsy: focusing on monocyte infiltration.

Authors:  Dale B Bosco; Dai-Shi Tian; Long-Jun Wu
Journal:  FEBS J       Date:  2020-06-15       Impact factor: 5.542

Review 3.  Small Heat Shock Proteins, Amyloid Fibrils, and Nicotine Stimulate a Common Immune Suppressive Pathway with Implications for Future Therapies.

Authors:  Jonathan B Rothbard; Michael P Kurnellas; Shalina S Ousman; Sara Brownell; Jesse J Rothbard; Lawrence Steinman
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

Review 4.  A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis.

Authors:  Soudeh Ghafouri-Fard; Kasra Honarmand; Mohammad Taheri
Journal:  Metab Brain Dis       Date:  2021-01-06       Impact factor: 3.584

5.  Activating α7 nicotinic acetylcholine receptor inhibits NLRP3 inflammasome through regulation of β-arrestin-1.

Authors:  Ping Ke; Bo-Zong Shao; Zhe-Qi Xu; Xiong-Wen Chen; Wei Wei; Chong Liu
Journal:  CNS Neurosci Ther       Date:  2017-09-21       Impact factor: 5.243

Review 6.  Nicotinic acetylcholine receptors in neuropathic and inflammatory pain.

Authors:  Arik J Hone; J Michael McIntosh
Journal:  FEBS Lett       Date:  2017-10-27       Impact factor: 4.124

7.  Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages.

Authors:  Wei Jiang; Daojing Li; Ranran Han; Chao Zhang; Wei-Na Jin; Kristofer Wood; Qiang Liu; Fu-Dong Shi; Junwei Hao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

8.  Identification of a common immune regulatory pathway induced by small heat shock proteins, amyloid fibrils, and nicotine.

Authors:  Jonathan B Rothbard; Jesse J Rothbard; Luis Soares; C Garrison Fathman; Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-18       Impact factor: 11.205

9.  Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain.

Authors:  Haylie K Romero; Sean B Christensen; Lorenzo Di Cesare Mannelli; Joanna Gajewiak; Renuka Ramachandra; Keith S Elmslie; Douglas E Vetter; Carla Ghelardini; Shawn P Iadonato; Jose L Mercado; Baldomera M Olivera; J Michael McIntosh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-21       Impact factor: 11.205

10.  Cholinergic imbalance in lumbar spinal cord of a rat model of multiple sclerosis.

Authors:  Chunling Liu; Hui Liu; Hongjun Jin; Xuyi Yue; Zonghua Luo; Zhude Tu
Journal:  J Neuroimmunol       Date:  2018-02-12       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.